Aromatase inhibitors are to become more widely available for post-menopausal women with early breast cancer.As expected, NICE's final appraisal determination …
UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …
A new report has revealed large differences in how NHS money is spent across England, with some PCTs spending much …
The British Medical Association is questioning the government over a possible 300 million pound drop in funding available for medical …
An NHS watchdog has urged renewed efforts to cut the number of drug errors by improving prescribing and dispensing in …
A generic company has launched a version of blood-thinning blockbuster product Plavix in the US, threatening the $3.3 billion sales …
GlaxoSmithKline's pharmaceutical sales rose by 10% in this year's second quarter earning the company a total of five billion pounds.Sales …
Accelerated sales of predicted blockbuster depression treatment Cymbalta have helped boost Lilly sales for the second quarter of 2006.The drug …
The aim of every company, pharma or otherwise, is to boost sales and take a greater market share. However, despite …
Japanese pharmaceutical company Takeda has chosen London as the site of its new four million pound European sales and marketing …
Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …
Pfizer's new kidney cancer drug Sutent is rapidly catching up with its recently approved rival, Bayer's Nexavar.Sutent (sunitinib) has been …
Crestor was AstraZeneca's most rapidly expanding product in terms of European sales in the second quarter of this year. Sales …
Pfizer's potential blockbuster smoking cessation drug Champix has been recommended for European approval by a key EMEA committee.The first-in-class treatment …
AstraZeneca's blockbuster gastro-oesophageal reflux disease treatment Nexium has come out ahead of Wyeth's Zoton in a new study, which showed …
MDS Pharma Services has been named Europe's best provider of clinical research services in a survey of trial investigators.Conducted by …
The first-ever cervical cancer vaccine is set for approval in Europe following its recommendation from a key advisory committee.The positive …
Marrying traditional techniquesDespite researchers' natural leaning towards either qualitative or quantitative research, it is clear that the two types of …
A new organisation has been set up to give the medicines regulatory agency independent advice on how to improve patient …
David Nicholson, the current head of the health service in London has been named as the new NHS chief executive.With …